Index -
P/E -
EPS (ttm) -0.14
Insider Own 2.91%
Shs Outstand 91.26M
Perf Week 8.61%
Market Cap 6.66B
Forward P/E 18.09
EPS next Y 3.97
Insider Trans -6.50%
Shs Float 90.08M
Perf Month -4.23%
Income -11.30M
PEG -
EPS next Q 0.92
Inst Own 100.32%
Short Float 3.56%
Perf Quarter -12.49%
Sales 2.99B
P/S 2.23
EPS this Y 2.50%
Inst Trans -8.05%
Short Ratio 4.56
Perf Half Y -2.56%
Book/sh 31.30
P/B 2.29
EPS next Y 12.60%
ROA -0.21%
Short Interest 3.21M
Perf Year 2.84%
Cash/sh 0.83
P/C 86.18
EPS next 5Y 10.26%
ROE -0.40%
52W Range 64.74 - 87.77
Perf YTD -7.65%
Dividend Est. -
P/FCF -
EPS past 5Y 34.75%
ROI -0.24%
52W High -18.18%
Beta 1.34
Dividend TTM -
Quick Ratio 1.25
Sales past 5Y 1.29%
Gross Margin 23.52%
52W Low 10.92%
ATR (14) 2.30
Dividend Ex-Date -
Current Ratio 1.27
EPS Y/Y TTM -104.04%
Oper. Margin 17.49%
RSI (14) 49.93
Volatility 4.15% 3.10%
Employees 23500
Debt/Eq 0.69
Sales Y/Y TTM 10.92%
Profit Margin -0.38%
Recom 1.54
Target Price 89.69
Option/Short Yes / Yes
LT Debt/Eq 0.66
EPS Q/Q 14.94%
Payout -
Rel Volume 2.39
Prev Close 70.49
Sales Surprise -1.43%
EPS Surprise 5.41%
Sales Q/Q 9.06%
Earnings May 01 AMC
Avg Volume 703.35K
Price 71.81
SMA20 1.62%
SMA50 -4.88%
SMA200 -5.76%
Trades
Volume 1,678,270
Change 1.87%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-25-24 Upgrade
Deutsche Bank
Sell → Hold
$70
Mar-06-24 Initiated
Barclays
Overweight
$100
Apr-21-23 Initiated
Cantor Fitzgerald
Neutral
$83
Apr-20-23 Downgrade
Deutsche Bank
Hold → Sell
$75 → $63
Dec-12-22 Upgrade
Loop Capital
Hold → Buy
$90 → $95
Jun-17-22 Initiated
Loop Capital
Hold
$72
Sep-27-21 Initiated
SVB Leerink
Outperform
$85
Sep-24-21 Initiated
UBS
Buy
$81
Sep-20-21 Upgrade
Credit Suisse
Neutral → Outperform
$68
Sep-10-21 Initiated
Cowen
Outperform
$79
Aug-12-21 Initiated
Barclays
Underweight
$69
Jul-09-21 Initiated
Seaport Global Securities
Neutral
Nov-17-20 Upgrade
UBS
Neutral → Buy
$37 → $54
Sep-30-20 Upgrade
Raymond James
Outperform → Strong Buy
$40 → $48
Jan-28-20 Initiated
Stephens
Equal-Weight
$36
Dec-11-19 Downgrade
Wells Fargo
Outperform → Market Perform
Jul-31-19 Downgrade
Raymond James
Strong Buy → Outperform
$45
Jan-03-19 Initiated
Deutsche Bank
Hold
$27
Nov-16-18 Initiated
UBS
Neutral
$39
Jan-30-18 Resumed
Wells Fargo
Outperform
Show Previous Ratings
May-09-24 11:21AM
May-08-24 04:21AM
May-07-24 02:23PM
11:00AM
May-06-24 12:46PM
03:44PM
Loading…
May-03-24 03:44PM
03:23AM
May-02-24 11:01PM
(Thomson Reuters StreetEvents) -8.58%
04:41AM
03:56AM
May-01-24 08:55PM
06:44PM
05:45PM
04:43PM
(Associated Press Finance)
04:05PM
11:52AM
Loading…
Apr-12-24 11:52AM
Apr-11-24 02:16PM
Apr-05-24 11:54AM
Apr-04-24 09:00AM
Apr-03-24 01:25PM
11:00AM
Apr-02-24 09:00AM
Apr-01-24 01:18PM
Mar-28-24 12:39PM
11:30AM
10:00AM
Mar-27-24 01:13PM
Mar-11-24 03:00PM
Mar-06-24 11:56PM
Mar-05-24 09:59AM
09:16AM
Loading…
Feb-29-24 09:16AM
Feb-28-24 09:53PM
(Thomson Reuters StreetEvents)
04:00PM
09:13AM
Feb-27-24 06:25PM
05:52PM
05:32PM
(Associated Press Finance)
04:05PM
Feb-23-24 11:12AM
Feb-21-24 03:06PM
Feb-20-24 01:00PM
Feb-15-24 03:04PM
Feb-07-24 10:00AM
Jan-30-24 01:32PM
Jan-24-24 09:40AM
Jan-10-24 12:56PM
Jan-09-24 01:15PM
01:15PM
Jan-08-24 11:47AM
09:40AM
Jan-05-24 09:50AM
Jan-04-24 09:40AM
Jan-03-24 11:00AM
Dec-15-23 01:01PM
12:53PM
Dec-14-23 06:38PM
Dec-13-23 02:55PM
Dec-11-23 09:50AM
Dec-08-23 08:58AM
Dec-05-23 04:09PM
Nov-21-23 09:44AM
Nov-20-23 09:40AM
Nov-17-23 05:03AM
Nov-13-23 11:04PM
Nov-09-23 11:00AM
Nov-05-23 01:50PM
Nov-03-23 10:59PM
(Thomson Reuters StreetEvents)
11:52AM
09:40AM
08:52AM
Nov-02-23 07:22PM
05:34PM
(Associated Press Finance)
04:11PM
Nov-01-23 01:54PM
Oct-26-23 04:05PM
03:15PM
Oct-23-23 09:50AM
Oct-12-23 11:37AM
Oct-11-23 09:55AM
Oct-10-23 09:40AM
Oct-09-23 09:45AM
Sep-29-23 08:38AM
Sep-27-23 12:00PM
09:35AM
Sep-25-23 12:47PM
Sep-20-23 07:18AM
Sep-15-23 09:40AM
Sep-13-23 09:45AM
Sep-01-23 09:00AM
Aug-30-23 09:40AM
Aug-24-23 11:47AM
Aug-07-23 06:16AM
Aug-03-23 01:46PM
Jul-30-23 08:31AM
Jul-29-23 12:31AM
(Thomson Reuters StreetEvents)
Jul-28-23 12:42PM
Jul-27-23 06:55PM
05:54PM
04:05PM
Jul-25-23 12:04PM
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services across the United States. The firm provides services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. The company was founded in January 2005 and is headquartered in Franklin, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Miquelon Wade D Director Mar 05 '24 Sale 85.39 2,203 188,114 46,074 Mar 06 05:30 PM Gregg Vicky B Director Mar 04 '24 Sale 85.56 2,500 213,900 26,851 Mar 06 05:28 PM OSTEEN DEBRA K Director Dec 13 '23 Sale 77.67 35,000 2,718,450 675,833 Dec 14 09:14 PM OSTEEN DEBRA K Director Dec 12 '23 Sale 76.23 8,000 609,840 710,833 Dec 14 09:14 PM Hollinsworth John S. EVP of Operations Nov 14 '23 Sale 74.01 92,500 6,846,300 84,630 Nov 16 05:01 PM Hollinsworth John S. EVP of Operations Nov 10 '23 Sale 73.00 20,000 1,460,000 177,130 Nov 13 05:42 PM OSTEEN DEBRA K Director Nov 08 '23 Sale 74.21 15,000 1,113,150 718,833 Nov 13 05:33 PM Hollinsworth John S. EVP of Operations Nov 08 '23 Sale 74.50 12,500 931,250 197,130 Nov 13 05:42 PM
Index S&P 500
P/E 18.63
EPS (ttm) 7.43
Insider Own 0.44%
Shs Outstand 111.00M
Perf Week 0.76%
Market Cap 15.38B
Forward P/E 14.63
EPS next Y 9.46
Insider Trans -3.57%
Shs Float 110.60M
Perf Month 6.46%
Income 842.00M
PEG 3.75
EPS next Q 2.34
Inst Own 91.13%
Short Float 2.53%
Perf Quarter 9.22%
Sales 9.29B
P/S 1.66
EPS this Y 1.33%
Inst Trans -1.34%
Short Ratio 2.85
Perf Half Y 3.71%
Book/sh 57.95
P/B 2.39
EPS next Y 7.22%
ROA 6.30%
Short Interest 2.80M
Perf Year 4.52%
Cash/sh 4.27
P/C 32.44
EPS next 5Y 4.96%
ROE 13.49%
52W Range 119.59 - 145.58
Perf YTD 0.39%
Dividend Est. 2.89 (2.09%)
P/FCF 16.24
EPS past 5Y 7.36%
ROI 7.85%
52W High -4.92%
Beta 0.89
Dividend TTM 2.88 (2.08%)
Quick Ratio 0.89
Sales past 5Y 4.86%
Gross Margin 31.88%
52W Low 15.75%
ATR (14) 2.66
Dividend Ex-Date Apr 05, 2024
Current Ratio 0.97
EPS Y/Y TTM 9.66%
Oper. Margin 14.48%
RSI (14) 60.53
Volatility 1.45% 2.03%
Employees 48000
Debt/Eq 0.83
Sales Y/Y TTM -3.29%
Profit Margin 9.07%
Recom 2.40
Target Price 147.24
Option/Short Yes / Yes
LT Debt/Eq 0.67
EPS Q/Q -3.13%
Payout 37.76%
Rel Volume 0.58
Prev Close 138.16
Sales Surprise 3.46%
EPS Surprise 9.94%
Sales Q/Q 1.50%
Earnings Apr 23 BMO
Avg Volume 983.21K
Price 138.42
SMA20 3.46%
SMA50 5.63%
SMA200 5.69%
Trades
Volume 569,562
Change 0.19%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$135
Feb-07-24 Upgrade
Jefferies
Hold → Buy
$140 → $155
Jan-03-24 Initiated
Barclays
Equal Weight
$145
Dec-12-23 Upgrade
BofA Securities
Neutral → Buy
$140 → $160
Jun-29-23 Initiated
Piper Sandler
Neutral
May-02-23 Downgrade
BofA Securities
Buy → Neutral
$166 → $148
Apr-03-23 Upgrade
Citigroup
Sell → Neutral
$125 → $142
Jan-23-23 Initiated
Evercore ISI
In-line
$159
Nov-17-22 Downgrade
Citigroup
Neutral → Sell
$145 → $125
Aug-22-22 Resumed
Morgan Stanley
Equal-Weight
$142
Apr-04-22 Downgrade
Citigroup
Buy → Neutral
$175 → $140
Feb-23-22 Downgrade
UBS
Buy → Neutral
$160 → $139
Feb-02-22 Downgrade
Jefferies
Buy → Hold
$135
Jan-28-22 Downgrade
Deutsche Bank
Buy → Hold
$190 → $129
May-04-21 Upgrade
UBS
Neutral → Buy
$135 → $158
Mar-12-21 Downgrade
Robert W. Baird
Outperform → Neutral
$137
Oct-21-20 Upgrade
Argus
Hold → Buy
Jul-29-20 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$144
Jul-14-20 Upgrade
BofA Securities
Neutral → Buy
$142
Jun-09-20 Upgrade
Wells Fargo
Underweight → Equal Weight
$90 → $120
Show Previous Ratings
May-08-24 12:30PM
May-07-24 04:50PM
11:23AM
May-06-24 02:00PM
09:40AM
10:42AM
Loading…
May-02-24 10:42AM
09:02AM
08:10AM
01:23AM
May-01-24 10:44AM
06:57AM
Apr-30-24 08:37AM
Apr-26-24 08:45AM
01:05AM
Apr-25-24 11:13AM
03:02AM
Loading…
Apr-24-24 03:02AM
Apr-23-24 10:35PM
(Thomson Reuters StreetEvents) +5.08%
09:58PM
10:52AM
09:54AM
08:01AM
07:55AM
07:55AM
06:52AM
(Associated Press Finance)
06:45AM
Apr-22-24 09:16AM
07:53AM
Apr-16-24 10:00AM
Apr-15-24 09:47AM
09:15AM
12:00PM
Loading…
Apr-09-24 12:00PM
Apr-04-24 07:05AM
Apr-03-24 11:22AM
Apr-02-24 07:57AM
Apr-01-24 02:30PM
Mar-26-24 12:30PM
07:09AM
Mar-20-24 11:15AM
Mar-19-24 03:06PM
Mar-14-24 01:20PM
Mar-06-24 01:45PM
Mar-05-24 12:15PM
Mar-04-24 02:45PM
Mar-01-24 09:36AM
Feb-29-24 01:45PM
Feb-27-24 02:30PM
12:19PM
Feb-24-24 12:06AM
Feb-23-24 11:24PM
11:30AM
09:35AM
Feb-21-24 12:00PM
Feb-15-24 07:58AM
06:00AM
Feb-13-24 08:16AM
08:07AM
Feb-12-24 08:01AM
Feb-06-24 07:14AM
Feb-05-24 07:17PM
Feb-02-24 10:10AM
Feb-01-24 10:56PM
(Thomson Reuters StreetEvents)
06:06PM
12:58PM
09:30AM
09:27AM
07:55AM
07:11AM
(Associated Press Finance)
06:45AM
Jan-31-24 02:50PM
Jan-29-24 12:45PM
Jan-26-24 04:07PM
09:15AM
Jan-22-24 08:07AM
Jan-19-24 07:25AM
Jan-18-24 07:18AM
05:04AM
Jan-17-24 09:35AM
08:58AM
Jan-15-24 07:46AM
05:02AM
Jan-10-24 09:40AM
Jan-09-24 01:01PM
08:05AM
Jan-08-24 08:56AM
07:07AM
Jan-04-24 10:00AM
Jan-03-24 01:45PM
Dec-21-23 01:04PM
Dec-20-23 07:34AM
07:01AM
Dec-19-23 10:45AM
08:54AM
Dec-18-23 10:30AM
07:47AM
Dec-14-23 08:53AM
Dec-13-23 03:15PM
Dec-11-23 10:15AM
Dec-08-23 07:25AM
Dec-07-23 01:50PM
08:01AM
Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
KUPPUSAMY KARTHIK SVP, Clinical Solutions Apr 29 '24 Sale 140.00 1,760 246,400 13,435 May 01 04:26 PM PREVOZNIK MICHAEL E SVP & General Counsel Feb 29 '24 Sale 125.88 5,611 706,313 38,478 Mar 01 04:50 PM Doherty Catherine T. EVP, Regional Businesses Feb 29 '24 Sale 125.88 1,187 149,420 68,412 Mar 01 04:51 PM Doherty Catherine T. EVP, Regional Businesses Feb 28 '24 Sale 126.57 5,557 703,349 69,599 Mar 01 04:51 PM Gregg Vicky B Director Feb 23 '24 Sale 126.64 2,500 316,596 16,329 Feb 23 04:34 PM Doherty Catherine T. EVP, Regional Businesses Feb 22 '24 Sale 126.14 821 103,561 70,800 Feb 23 04:32 PM PREVOZNIK MICHAEL E SVP & General Counsel Feb 22 '24 Sale 126.14 661 83,379 40,206 Feb 23 04:35 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite